Clinical Case Reports (Feb 2022)

Fulminant myocarditis after the second dose of COVID‐19 mRNA vaccination

  • Akihiro Oka,
  • Yuya Sudo,
  • Toru Miyoshi,
  • Masatomo Ozaki,
  • Yuta Kimura,
  • Wataru Takagi,
  • Satoko Ugawa,
  • Tomoaki Okada,
  • Kazumasa Nosaka,
  • Masayuki Doi

DOI
https://doi.org/10.1002/ccr3.5378
Journal volume & issue
Vol. 10, no. 2
pp. n/a – n/a

Abstract

Read online

Abstract Myocarditis is an adverse event associated with coronavirus disease 2019 (COVID‐19) mRNA vaccination. A 50‐year‐old man presented with dyspnea and resting chest pain after receiving the second dose of the COVID‐19 mRNA vaccine and developed cardiogenic shock. Fulminant myocarditis was diagnosed by endomyocardial biopsy and treated with intravenous corticosteroids.

Keywords